论文部分内容阅读
Characterization of a Novel Anti-DR5 Monoclonal Antibody WD1 with the Potential to Induce Tumor Cell
【作 者】
：
【出 处】
：
中国免疫学杂志（英文版）
【发表日期】
：
2008年1期
其他文献
【摘 要】目的： 探讨米非司酮联合利凡诺用于中期妊娠引产的效果。方法：将80例中期妊娠要求引产的健康妇女随机分为两组，实验组40例经腹羊膜腔内注入利凡诺100 mg，于注药当天口服米非司酮50 mg，2次/d，总量150 mg。对照组40例单用利凡诺引产。结果：实验组平均宫缩发动时间、胎儿娩出时间均短于对照组，两组比较差异有统计学意义(P<0.01)；产后胎盘、胎膜残留清宫率，对照组为9.12%
期刊
硬脊膜损伤是脊柱手术常见的并发症之一.如果处理不当往往导致脑脊液漏,进而形成硬脊膜假性囊肿,引起神经根损伤,严重者可以发生感染,引起蛛网膜炎或脑膜炎,甚至合并脑脓肿及
Inhibition of NF-κB Expression and Allergen-induced Airway Inflammation in a Mouse Allergic Asthma M
Andrographolide from traditional Chinese herbal medicines previously showed it possesses a strong anti-inflammatory activity. In present study, we investigated
【关键词】稽留流产；米非司酮；米索前列醇 【中图分类号】R96 【文献标识码】A 【文章编号】1008-6455（2012）01-0300-01 稽留流产，由于胚胎死亡时间长，组织机化，与子宫壁粘连较紧，处理比较困难。我科采用米非司酮联合米索前列醇在清宫前应用，取得了较好的效果。现报道如下。 1 资料与方法 1.1一般资料 取自我院2010年1月-2010年12月门诊与住院的
期刊
The Functional Roles of Lipid Rafts in T-Cell Activation, Immune Diseases and HIV Infection and Prev
The first appearance of lipid rafts, or lipid rafts-like structure, was occasionally observed by cryo-electronic microscopy in 1980s as cavity, such as caveolae
Fine-Tuned Expression of Programmed Death 1 Ligands in Mature Dendritic Cells Stimulated by CD40 Lig
During maturation, murine myeloid dendritic cells(DCs)upregulated the expressions of CD11c, CD25, CD40, CD80, CD86.MHc II and programmed death 1 ligands 1 and 2
目的 观察杏丁注射液治疗慢性肾功能不全的疗效.方法 将入选的120例患者按入院顺序随机分为对照组和杏丁注射液治疗组.于4周后分别进行肾功能(BUN、Scr)、尿蛋白、血脂(TG、TC)、肾动脉阻力指数(RI)、肝功能、血常规、血电解质等相关指标检测.结果 杏丁组治疗4周后BUN、Scr、Tp/24 h、TG、TC、RI较治疗前明显下降(P＜0.05).且较对照组治疗后差异有统计学意义(P＜0.05
IL-10 Gene Modified Dendritic Cells Inhibit T Helper Type 1-Mediated Alloimmune Responses and Promot
Dendritic cells (DCs)have the potency to regulate the outcome of autoimmunity through the modulation of immune responses. The induction of antigen specific tole
总结急性心肌梗塞患者住院期间的常规护理、心理护理以及患者对疾病的态度.通过对急性心肌梗塞患者进行密切全面细致的护理,使患者消除心里顾虑,积极配合治疗从而早自恢复健
Atificial antigen-presenting cells are expected to stimulate the expansion and acquisition of optimal therapeutic features of T cells before infusion. Here CD32